Display options
Cite
Ezzati M, Abdullah A, Shariftabrizi A, et al. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. Int Sch Res Notices. 2014;2014:953509doi: 10.1155/2014/953509.
Ezzati, M., Abdullah, A., Shariftabrizi, A., Hou, J., Kopf, M., Stedman, J. K., Samuelson, R., & Shahabi, S. (2014). Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. International scholarly research notices, 2014953509. https://doi.org/10.1155/2014/953509
Ezzati, Mohammad, et al. "Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma." International scholarly research notices vol. 2014 (2014): 953509. doi: https://doi.org/10.1155/2014/953509
Ezzati M, Abdullah A, Shariftabrizi A, Hou J, Kopf M, Stedman JK, Samuelson R, Shahabi S. Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma. Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014. PMID: 27382614; PMCID: PMC4897239.
Copy Download .nbib Format: NLM
Share it on

Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014.

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.

International scholarly research notices

Mohammad Ezzati, Amer Abdullah, Ahmad Shariftabrizi, June Hou, Michael Kopf, Jennifer K Stedman, Robert Samuelson, Shohreh Shahabi

Affiliations

  1. Department of Obstetrics and Gynecology, Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, USA; Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.
  2. Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.
  3. Department of Pathology and Laboratory Medicine, School of Medicine, Tufts University, 800 Washington Street, Boston, MA 02111, USA.
  4. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine and Montefiore Medical Center, Montefiore Centennial, 3332 Rochambeau Avenue, Bronx, NY 10467-2836, USA.
  5. Department of Medicine, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.

PMID: 27382614 PMCID: PMC4897239 DOI: 10.1155/2014/953509

Abstract

Ovarian cancer remains the most common cause of gynecologic cancer-related death among women in developed countries. Nevertheless, subgroups of ovarian cancer patients experience relatively longer survival. Efforts to identify prognostic factors that characterize such patients are ongoing, with investigational areas including tumor characteristics, surgical management, inheritance patterns, immunologic factors, and genomic patterns. This review discusses various demographic, clinical, and molecular factors implicating longevity and ovarian cancer survival. Continued efforts at identifying these prognosticators may result in invaluable adjuncts to the treatment of ovarian cancer, with the ultimate goal of advancing patient care.

References

  1. Genes Chromosomes Cancer. 1999 Jun;25(2):91-6 - PubMed
  2. Int J Gynecol Pathol. 2000 Jan;19(1):7-15 - PubMed
  3. Gynecol Oncol. 2000 Mar;76(3):294-300 - PubMed
  4. Am J Hum Genet. 2000 Apr;66(4):1259-72 - PubMed
  5. Int J Gynaecol Obstet. 2000 Aug;70(2):209-62 - PubMed
  6. Am J Hum Genet. 2001 Mar;68(3):700-10 - PubMed
  7. Int J Gynecol Cancer. 2000 Jul;10(4):289-295 - PubMed
  8. Gynecol Oncol. 2001 Jun;81(3):398-403 - PubMed
  9. Gynecol Oncol. 2001 Sep;82(3):532-7 - PubMed
  10. Br J Cancer. 2001 Sep 28;85(7):944-52 - PubMed
  11. Cancer Causes Control. 2001 Nov;12(9):855-63 - PubMed
  12. J Clin Oncol. 2002 Mar 1;20(5):1248-59 - PubMed
  13. Cancer. 2002 Apr 1;94(7):1961-7 - PubMed
  14. Gynecol Oncol. 2002 Jun;85(3):431-4 - PubMed
  15. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):822-8 - PubMed
  16. Natl Cancer Inst Monogr. 1975 Oct;42:101-4 - PubMed
  17. Eur J Cancer. 2002 Dec;38(18):2435-45 - PubMed
  18. J Natl Cancer Inst. 2003 Jan 15;95(2):94-5 - PubMed
  19. J Natl Cancer Inst. 2003 Jan 15;95(2):105-12 - PubMed
  20. J Natl Cancer Inst. 2003 Jan 15;95(2):113-25 - PubMed
  21. J Natl Cancer Inst. 2003 Jan 15;95(2):125-32 - PubMed
  22. N Engl J Med. 2003 Apr 24;348(17):1625-38 - PubMed
  23. Cancer. 2003 May 1;97(9):2187-95 - PubMed
  24. Obstet Gynecol. 2003 Jul;102(1):156-61 - PubMed
  25. Gynecol Oncol. 2003 Dec;91(3):563-8 - PubMed
  26. Gynecol Oncol. 1992 Nov;47(2):159-66 - PubMed
  27. J Clin Oncol. 2004 Mar 15;22(6):1040-4 - PubMed
  28. Nat Med. 2004 Sep;10(9):942-9 - PubMed
  29. Gynecol Oncol. 2004 Nov;95(2):377-83 - PubMed
  30. Clin Cancer Res. 2005 Jan 1;11(1):67-72 - PubMed
  31. Cancer. 2005 Apr 1;103(7):1397-401 - PubMed
  32. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1307-10 - PubMed
  33. Clin Cancer Res. 2005 May 15;11(10):3686-96 - PubMed
  34. J Reprod Med. 2005 Jun;50(6):467-74 - PubMed
  35. Hum Pathol. 2005 Aug;36(8):861-70 - PubMed
  36. Gynecol Oncol. 2005 Nov;99(2):447-61 - PubMed
  37. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18538-43 - PubMed
  38. J Surg Oncol. 2007 May 1;95(6):476-84 - PubMed
  39. Eur J Cancer. 2007 Mar;43(4):690-709 - PubMed
  40. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66 - PubMed
  41. Int J Oncol. 2007 Mar;30(3):727-34 - PubMed
  42. Clin Cancer Res. 2007 Jun 15;13(12):3591-6 - PubMed
  43. J Clin Oncol. 2007 Jul 10;25(20):2873-83 - PubMed
  44. Gynecol Oncol. 2007 Nov;107(2):260-5 - PubMed
  45. Semin Cancer Biol. 2007 Dec;17(6):436-43 - PubMed
  46. Int J Gynecol Cancer. 2008 May-Jun;18(3):487-91 - PubMed
  47. J Clin Oncol. 2007 Aug 20;25(24):3621-7 - PubMed
  48. Nat Rev Genet. 2007 Oct;8(10):735-48 - PubMed
  49. Ann Oncol. 2007 Nov;18(11):1804-9 - PubMed
  50. Gynecol Oncol. 2008 Jan;108(1):191-4 - PubMed
  51. J Clin Oncol. 2008 Jan 1;26(1):20-5 - PubMed
  52. Eur J Cancer. 1991;27(11):1367-72 - PubMed
  53. J Clin Oncol. 2008 Jun 10;26(17):2846-53 - PubMed
  54. J Clin Oncol. 1991 Jul;9(7):1138-50 - PubMed
  55. Cancer. 2009 Feb 15;115(4):812-22 - PubMed
  56. Br J Cancer. 2009 Jul 7;101(1):149-59 - PubMed
  57. Int J Gynecol Cancer. 2009 Oct;19(7):1205-13 - PubMed
  58. J Pathol. 2010 May;221(1):49-56 - PubMed
  59. Int J Gynecol Cancer. 2010 Aug;20(6):945-52 - PubMed
  60. J Surg Oncol. 2010 Nov 1;102(6):656-62 - PubMed
  61. J Natl Cancer Inst. 2010 Oct 20;102(20):1547-56 - PubMed
  62. Nature. 2011 Jun 29;474(7353):609-15 - PubMed
  63. N Engl J Med. 1990 Apr 12;322(15):1021-7 - PubMed
  64. Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565 - PubMed
  65. Eur J Surg Oncol. 2011 Nov;37(11):971-7 - PubMed
  66. JAMA. 2011 Oct 12;306(14):1557-65 - PubMed
  67. Eur J Cancer. 2012 Jul;48(10):1476-83 - PubMed
  68. Int J Gynecol Cancer. 2011 Dec;21(9):1525-32 - PubMed
  69. BMC Syst Biol. 2012 Jan 11;6:3 - PubMed
  70. Int J Gynecol Cancer. 2012 Mar;22(3):367-71 - PubMed
  71. Gynecol Oncol. 2012 Jun;125(3):655-60 - PubMed
  72. Int J Gynecol Cancer. 2012 Mar;22(3):394-9 - PubMed
  73. Cancer Genet. 2012 Jan-Feb;205(1-2):34-41 - PubMed
  74. Cancer Sci. 2012 Jul;103(7):1334-41 - PubMed
  75. Cancer Prev Res (Phila). 2012 Jul;5(7):901-10 - PubMed
  76. Biol Direct. 2012 Jul 03;7:21 - PubMed
  77. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD005343 - PubMed
  78. Gynecol Oncol. 2013 Mar;128(3):512-7 - PubMed
  79. J Natl Cancer Inst. 2013 Jan 16;105(2):141-8 - PubMed
  80. CA Cancer J Clin. 2013 Jan;63(1):11-30 - PubMed
  81. Gynecol Oncol. 2013 May;129(2):353-7 - PubMed
  82. J Cancer Res Clin Oncol. 2013 Aug;139(8):1257-77 - PubMed
  83. Gynecol Oncol. 2013 Sep;130(3):554-9 - PubMed
  84. Gynecol Oncol. 2013 Sep;130(3):565-9 - PubMed
  85. Cancers (Basel). 2010 May 26;2(2):913-54 - PubMed
  86. Oncotarget. 2014 Jul 15;5(13):4855-67 - PubMed
  87. PLoS One. 2014 Jul 02;9(7):e101065 - PubMed
  88. Ann Intern Med. 1988 Feb;108(2):165-70 - PubMed
  89. J Clin Oncol. 1986 Apr;4(4):515-23 - PubMed
  90. J Chronic Dis. 1979;32(8):563-76 - PubMed
  91. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727-33 - PubMed
  92. Cancer Treat Rep. 1977 Oct;61(7):1307-17 - PubMed
  93. Gynecol Oncol. 1983 Jun;15(3):422-7 - PubMed
  94. Am J Obstet Gynecol. 1982 Dec 15;144(8):885-9 - PubMed
  95. Am J Clin Oncol. 1982 Dec;5(6):649-55 - PubMed
  96. Cancer. 1980 Feb;45(3):572-81 - PubMed
  97. Eur J Cancer. 1994;30A(3):344-50 - PubMed
  98. Gynecol Oncol. 1993 May;49(2):236-9 - PubMed
  99. Gynecol Oncol. 1996 Apr;61(1):109-12 - PubMed
  100. Cancer. 1996 Mar 15;77(6):1131-6 - PubMed
  101. Epidemiology. 1996 Jan;7(1):38-45 - PubMed
  102. Nat Genet. 1996 Oct;14(2):185-7 - PubMed
  103. N Engl J Med. 1996 Nov 7;335(19):1413-6 - PubMed
  104. Cell. 1997 Jan 24;88(2):265-75 - PubMed
  105. Cancer. 1998 Mar 1;82(5):893-901 - PubMed
  106. Oncology (Williston Park). 1998 Mar;12(3):399-406; discussion 409-10, 413 - PubMed
  107. Gynecol Oncol. 1998 May;69(2):103-8 - PubMed
  108. Gynecol Oncol. 1998 Jul;70(1):2-12 - PubMed

Publication Types